Synaffix’s Licensing Agreement with Amgen

Goodwin Procter advised Synaffix on the deal. Synaffix announced a licensing agreement with Amgen to develop next generation of antibody-drug conjugates (ADCs) using Synaffix technology. Under the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Alvarium Investments’ $1.4 Billion Business Combination with Tiedemann Group and Cartesian Growth Corporation

Goodwin Procter and Appleby advised Alvarium Investments on the deal. Seward & Kissel represented Tiedemann Advisors and TIG Advisors. Homburger advised Tiedemann Group and its Switzerland-based...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here